Cite
HARVARD Citation
Furman, W. et al. (2022). Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A. Journal of clinical oncology. 40 (4), pp. 335-344. [Online].